Breast Cancer Chemotherapy: Adverse Effects Higher Than Reported in Clinical Trials

The article focuses on the findings of a study on the prevalence of serious adverse effects of breast cancer chemotherapy conducted by a team of researchers led by Michael J. Hassett of the Center for Outcomes and Policy Research at Dana-Farber Cancer Institute in Massachusetts. The researchers found that breast cancer patients who received chemotherapy were more likely to be hospitalized than those who had not. Low blood counts and diarrhea are the common types of serious adverse reactions discovered. It details the significance of the study.

Share this with your friends
Breast Cancer Chemotherapy--Adverse side effects.pdf25.53 KB